Presentation by Brian Gfeller, Pfizer: Application of HT-MS to Support Process Analytical Characterization

Presentation by Sara Carillo, NIBRT: Characterizing AAV Quality Attributes Using Mass Spectrometry

Presentation by Bingchuan Wei, Genentech: Unveiling Structural-Function Relationship through Hydrogen Deuterium Exchange Coupled with Mass Spectrometry (HDX-MS)

Presentation by Rachel Shi, Genentech: Innovating Mass Spectrometry Approaches for Characterizing Emerging Modality Therapeutics

Presentation by Ben Niu, BMS: High-Throughput and Automation in Novel Modalities (bsAbs, ADCs) Characterizations and Beyond

Presentation by Serena Wu, Regeneron: Development of LCMS MAM for Protein and Oligonucleotide Therapies

Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug…

Presentation by Chris Chumsae, BMS: Mass Spec Allows Us to ‘See’ Molecules and Solve Mysteries

Presentation by Anita Liu, Merck: Use of MAM for In-Process Monitoring and Quality Control of Complex Biologics

Presentation by Joshua Coon, University of Wisconsin: Rapid Analysis of Therapeutic Antibodies by Direct Infusion Peptide Mapping